Alpha Cognition Total Liabilities and Share Holders Equity 2020-2024 | ACOG
Alpha Cognition total liabilities and share holders equity from 2020 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
Alpha Cognition Annual Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2023 |
$2 |
| 2022 |
$3 |
| 2021 |
$13 |
| 2020 |
$8 |
| 2019 |
$6 |
Alpha Cognition Quarterly Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2024-06-30 |
$2 |
| 2024-03-31 |
$3 |
| 2023-12-31 |
$2 |
| 2023-09-30 |
$2 |
| 2023-06-30 |
$2 |
| 2023-03-31 |
$5 |
| 2022-12-31 |
$3 |
| 2022-09-30 |
$4 |
| 2022-06-30 |
$7 |
| 2022-03-31 |
$11 |
| 2021-12-31 |
$13 |
| 2021-09-30 |
$6 |
| 2021-06-30 |
$6 |
| 2021-03-31 |
$8 |
| 2020-12-31 |
$8 |
| 2020-09-30 |
$0 |
| 2020-06-30 |
$0 |
| 2020-03-31 |
$0 |
| 2019-12-31 |
$6 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.035B |
$0.000B |
|
Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.
|
